Emerging practices in therapeutic targeting of neurodegenerative diseases by modulating protein kinases
• 大类 : 医学 - 3区
• 小类 : 神经科学 - 4区
Brain Research invites articles to the special issue, Emerging practices in therapeutic targeting of neurodegenerative diseases by modulating protein kinases.
Md. Imtaiyaz Hassan, Jamia Millia IslamiaBelgin Sever, Anadolu University
Special issue information:
Brain Research invites researchers to contribute their work to a special issue focusing on emerging practices in the therapeutic targeting of neurodegenerative diseases through the modulation of protein kinases. This special issue aims to provide a platform for disseminating cutting-edge research and innovative approaches that shed light on the potential of protein kinases as therapeutic targets.Neurodegenerative diseases pose a significant and growing challenge to public health globally. Despite extensive research, effective treatments for these debilitating conditions are still limited. Protein kinases, crucial regulators of various cellular processes, have emerged as promising targets for therapeutic intervention in neurodegenerative diseases.We invite original research articles, reviews, and perspectives exploring the latest advancements in the therapeutic targeting of neurodegenerative diseases by modulating protein kinases. Topics of interest for this special issue include, but are not limited to:1. Identification and characterization of novel protein kinases implicated in neurodegenerative diseases.2. Mechanistic insights into the role of protein kinases in disease pathogenesis and progression.3. Development and evaluation of small molecules, peptides, or biologics targeting protein kinases.4. Preclinical and clinical studies investigating the therapeutic potential of protein kinase modulation in neurodegenerative disorders.5. Advances in pharmacological approaches and drug delivery systems for targeting protein kinases.6. Combination therapies involving protein kinases as therapeutic targets.Authors are encouraged to present original research findings with implications for the clinical management and treatment of neurodegenerative diseases. Submissions should adhere to the journal's guidelines for formatting and ethical considerations.